<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-12-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products." FDA is issuing this draft guidance to help sponsors develop human nonprescription drug product proprietary names. This draft guidance describes best practices to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to violations of the Federal...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-27057</p>
    <p><strong>Publication Date:</strong> 2020-12-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/12/09/2020-27057/best-practices-in-developing-proprietary-names-for-human-nonprescription-drug-products-draft">https://www.federalregister.gov/documents/2020/12/09/2020-27057/best-practices-in-developing-proprietary-names-for-human-nonprescription-drug-products-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-27057</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
